<DOC>
	<DOC>NCT02059629</DOC>
	<brief_summary>The Eluna Family / Sentus BP Master Study is designed to confirm the safety of the new Eluna pacemaker family and the Sentus BP (bipolar) left ventricular lead. Furthermore the new wandless RF telemetry function "SafeSync" and the handling of the Sentus lead during implantation will be assessed.</brief_summary>
	<brief_title>Eluna Family / Sentus BP Master Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Patient is willing to participate in the study and provided written informed consent Patient meets standard indication for pacemaker or CRTP or CRTD therapy Patient accepts Home MonitoringÂ® concept Patient has legal capacity and ability to consent Patient with any contraindication to pacemaker and CRTP and CRTD therapy Patient under the age of 18 Pregnant or breastfeeding women Cardiac surgery planned within the next 6 months Life expectancy less than 12 months Participation in another cardiac clinical investigation with active treatment arm Group B only: Currently implanted with an endocardial or epicardial LV lead or had prior attempt to place a LV lead (for CRT implants only)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Eluna pacemaker family</keyword>
	<keyword>Sentus OTW BP L left ventricular lead</keyword>
	<keyword>Bradycardia</keyword>
	<keyword>SADE-free rate</keyword>
</DOC>